| Authors: |
Wang L; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Rowe RG; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA; Department of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA., Jaimes A; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Yu C; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Nam Y; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Pearson DS; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA., Zhang J; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA., Xie X; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Marion W; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA., Heffron GJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Daley GQ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA; Manton Center for Orphan Disease Research, Boston, MA, USA., Sliz P; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA; Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA. Electronic address: sliz@hkl.hms.harvard.edu. |
